Skip to main content

Vaping clinical trials at University of California Health

3 research studies open to eligible people

Showing trials for
  • Acute Effects of TCIG vs ECIG in PLWH

    open to eligible people ages 21-45

    Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.

    at UCLA

  • Secondhand Effects of E-Hookah Aerosol

    open to eligible people ages 21-49

    In the United States, exposure to secondhand smoke accounts for greater than 35,000 deaths annually from cardiovascular disease in never-smokers. Electronic (e-) hookahs are a new category of vaping devices gaining popularity among youth. While more is known on the acute effects of active hookah smoking and the literature is emerging on active e-hookah vaping, virtually nothing is known about the acute cardiovascular effects of secondhand exposure to e-hookah aerosol. The study aims to examine the acute effects of secondhand exposure of e-hookah aerosol on endothelial and vascular function. Eligible volunteers will be invited to participate in a total of 3 study visits (2-3 hours each): e-hookah aerosol exposure, charcoal-heated hookah smoke exposure (both delivered by a hookah smoking/vaping machine) and smoke-free room air. Non-invasive blood pressure and blood flow measurements will be taken before and after the exposure sessions.

    at UCLA

  • Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents

    open to eligible people ages 13-17

    Social media based intervention to support teens in their efforts to quit vaping.

    at UCSF

Our lead scientists for Vaping research studies include .

Last updated: